eleQtron is a deep-tech company and spin-off of the University of Siegen founded in 2020. It develops quantum processors based on trapped ions and uses its proprietary MAGIC technology (Magnetic Gradient Induced Coupling) to enable precise, scalable qubit control via microwaves. The company focuses on the industrial scaling and commercialization of quantum computing systems.
Investment Rounds
Capital activity and funding progression
| Amount | Date | Round |
|---|---|---|
| €57 M | May, 2026 | series-a |
Industries
Frequently Asked Questions
Where is EleQtron located?
EleQtron is located in Siegen, Germany.
What industries does EleQtron operate in?
EleQtron operates in the following industries: quantum computing, deep tech.
When was EleQtron founded?
EleQtron was founded on 2026-05-05.
How much total funding has EleQtron raised?
EleQtron has raised a total of $57,000,000.
Who are the investors in EleQtron?
The investors in EleQtron are: Schwarz Digits, European Innovation Council Fund, Earlybird, Ankaa Ventures, Precitec, NRW.BANK, IFB Hamburg, European Union, State of North Rhine-Westphalia.
Who are the founders of EleQtron?
The founders of EleQtron are: Jan Henrik Leisse.
What is EleQtron and what does the company do?
EleQtron is a German deep-tech company founded in 2020 that develops, produces, and operates ion trap-based quantum computers.
What is the unique technology used by EleQtron?
EleQtron uses a proprietary technology called MAGIC, which stands for Magnetic Gradient Induced Coupling. This method allows for the control of ion qubits using microwaves instead of traditional lasers, making the system more precise, scalable, and easier to miniaturize.
Where was EleQtron founded?
EleQtron was founded as a spin-off from the Chair of Quantum Optics at the University of Siegen in Germany.
What are the primary applications of EleQtron's quantum computers?
The quantum computers developed by EleQtron are designed to solve complex commercial and industrial problems in areas such as materials research, logistics, supply chain management, pharmaceutical development, and financial risk management.